Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever

被引:0
作者
Ali Şahin
Mehmet Emin Derin
Fatih Albayrak
Burak Karakaş
Yalçın Karagöz
机构
[1] Cumhuriyet University,Department of Internal Medicine – Rheumatology, Faculty of Medicine
[2] Sivas Cumhuriyet University,Department of Biostatistic, Medical Faculty
来源
Advances in Rheumatology | / 60卷
关键词
Anakinra; Canakinumab; Familial Mediterranean fever (FMF); Amyloidosis; Colchicine-resistant;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 97 条
[1]  
Ozdogan H(2019)Familial Mediterranean fever Presse Med 48 e61-e76
[2]  
Ugurlu S(2004)Increased frequency of familial Mediterranean fever in Central Anatolia, Turkey Clin Exp Rheumatol 22 S31-S33
[3]  
Onen F(2014)Familial Mediterranean fever: an updated review Eur J Rheumatol 1 21-33
[4]  
Sumer H(2005)Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study Medicine (Baltimore) 84 1-11
[5]  
Turkay S(2018)Pathology and diagnosis of renal non-AL amyloidosis J Nephrol 31 343-350
[6]  
Akyurek O(2016)Approach to the patients with inadequate response to colchicine in familial Mediterranean fever Best Pract Res Clin Rheumatol 30 296-303
[7]  
Tunca M(2016)EULAR recommendations for the management of familial Mediterranean fever Ann Rheum Dis 75 644-651
[8]  
Ozdogan H(2013)Evidence-based recommendations for the practical management of familial Mediterranean fever Semin Arthritis Rheum 43 387-391
[9]  
Sari I(2018)Nationwide experience with off-label use of Interleukin-1 targeting treatment in familial Mediterranean fever patients Arthritis Care Res 70 1090-1094
[10]  
Birlik M(2017)Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever Mod Rheumatol 27 350-355